Zalicus zalicus.com

Zalicus, formerly CombinatoRx, is a biopharmaceutical company focused on developing new medicines built from synergistic combinations of approved drugs, designed to attack disease on multiple fronts. CombinatoRx applies its proprietary combination drug discovery technology to identify new combination product candidates in a number of disease areas, including immunoinflammatory disease, oncology, metabolic disease, neurodegenerative disease, and infectious disease.

Zalicus, formerly CombinatoRx, is a biopharmaceutical company focused on developing new medicines built from synergistic combinations of approved drugs, designed to attack disease on multiple fronts. CombinatoRx applies its proprietary combination dr...Show all

See All Exits Recent Exits

Phone: 617-301-7000

Fax:

245 First Street
Third Floor
Cambridge, 02142
Massachusetts, United States

Zalicus - Investments & Acquisitions

Show Real Data
See all Recent Investments
Date Company Round Amount Co-investors
2014-07-15Epirus BiopharmaceuticalsMerger
2009-07-02Neuromed PharmaceuticalsMerger
See all 2 investments